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Patricia E. Grant,1,15 Monica H. Wojcik,1,6 Joan Stoler,6 Casie A. Genetti,6,16 Marieke F. van Dooren,17
Saskia M. Maas,18 Marielle Alders,18 Laurence Faivre,2,3,4 Arthur Sorlin,2,3,4,19 Grace Yoon,20
Binnaz Yalcin,3,* and Pankaj B. Agrawal1,6,16,*SummaryKDM4B is a lysine-specific demethylase with a preferential activity on H3K9 tri/di-methylation (H3K9me3/2)-modified histones. H3K9
tri/di-demethylation is an important epigenetic mechanism responsible for silencing of gene expression in animal development and
cancer. However, the role of KDM4B on human development is still poorly characterized. Through international data sharing, we gath-
ered a cohort of nine individuals with mono-allelic de novo or inherited variants in KDM4B. All individuals presented with dysmorphic
features and global developmental delay (GDD) with language andmotor skills most affected. Three individuals had a history of seizures,
and four had anomalies on brain imaging ranging from agenesis of the corpus callosum with hydrocephalus to cystic formations,
abnormal hippocampi, and polymicrogyria. In mice, lysine demethylase 4B is expressed during brain development with high levels
in the hippocampus, a region important for learning and memory. To understand how KDM4B variants can lead to GDD in humans,
we assessed the effect of KDM4B disruption on brain anatomy and behavior through an in vivo heterozygous mouse model
(Kdm4bþ/), focusing on neuroanatomical changes. In mutant mice, the total brain volume was significantly reduced with decreased
size of the hippocampal dentate gyrus, partial agenesis of the corpus callosum, and ventriculomegaly. This report demonstrates that
variants in KDM4B are associated with GDD/ intellectual disability and neuroanatomical defects. Our findings suggest that KDM4B
variation leads to a chromatinopathy, broadening the spectrum of this group of Mendelian disorders caused by alterations in epigenetic
machinery.Global developmental delay (GDD) affects 1%–3% of chil-
dren less than 5 years old, and a similar rate of intellectual
disability (ID) is present in older children.1 Taken together,
GDD and ID are a worldwide pediatric public health prob-
lem with a lifetime care cost of up to $1,000,000 per
child.2 GDD and ID are often associated with other develop-
mental disorders of childhood and can lead to increased
caregiver stress.1,3 The causes of GDD/ID are multifactorial;
data suggest that a majority of cases are secondary to a ge-
netic cause.1,4 For example, in severe ID, an estimated
62% of cases are secondary to de novo variants.4,5 A genetic
diagnosis can be extraordinarily important for a family to
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 2020 American Society of Human Genetics.and provide them with prognosis, validation, social sup-
port, educational services, and an understanding of reoccur-
rence risk.1,6 Our understanding of GDD/ID continues to
evolve with the advancements in sequencing technologies
and functional modeling leading to identification of novel
genes and associated pathogenic variants. Using exome
sequencing (ES), we have identified a cohort of nine indi-
viduals with GDD and heterozygous variants in KDM4B.
KDM4B (MIM: 609765, alterative name JMJD2B) is
a lysine-specific histone demethylase with a catalytic activ-
ity against different histone modifications, including
H3K9me3, H3K9me2, H3K36me3, H3K36me2, H4K20me2,
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that is enriched at constitutive and facultative heterochro-
matin, localized at pericentromeric and telomeric regions as
well as atnuclear lamina inmammaliancells.7Accumulation
of H3K9 methylation is associated with chromatin compac-
tion and gene repression.8 Previous studies of KDM4B have
primarily been in cancer models and have shown that
KDM4B is strongly regulated by multiple cellular stimuli,
including oxygen concentration andHiF1 alpha, androgens,
estrogen, and DNA damage.9–14
Recent data suggest that KDM4B is expressed during
brain development with high expression in the hippocam-
pus, a region important for learning and memory.15 In a
neuron-specific KDM4B (JMJD2B)-deficient mouse model,
its depletion was associated with an increase in total den-
dritic spine number within the hippocampus and a
notable decrease in maturity of the dendritic spines. These
mice also exhibited hyperactive behavior, had deficits in
their working memory, and were prone to seizures.15
This study suggests that KDM4B depletion alters connec-
tivity, particularly within the hippocampus. Several other
histone lysine demethylases have previously been linked
to neurodevelopmental disorders, including KDM5C,
which causes an X-linked intellectual disability syndrome,
and KDM6A, which has been implicated in Kabuki syn-
drome.16,17 In the case of KDM5C, its depletion is thought
to lead to altered dendritic development in the rodent cere-
bellar cortex, while haploinsufficiency of KDM6A in
Kabuki syndrome is thought to affect neural differentia-
tion.16,18 However, the role of KDM4B in human develop-
ment has not been investigated.
We identified a cohort of nine individuals with
extremely rare variants in KDM4B and presenting with
syndromic GDD/ID and neuroanatomical findings. Using
a heterozygous mouse model (Kdm4bþ/), we performed
a systematic assessment of brain regions to analyze neuro-
anatomical defects in this model and identified structural
anomalies compatible with those identified in our cohort.
Overall, this study highlights the importance of KDM4B in
human brain development and cognitive function.
We performed trio ES on an individual (I:2) who
presented with GDD, agenesis of the corpus callosum,
intracranial cysts leading to obstructive hydrocephalus,
seizures, abnormal hippocampi, and dysmorphic facial fea-
tures (Tables 1, S1, and S2) and identified a de novo
missense variant in KDM4B. International data sharing
through MatchMaker Exchange allowed us to identify
eight additional individuals carrying raremissense variants
in this gene with an overlapping clinical spectrum
(Figure 1A; Table 1). In order to better delineate the symp-
tomatology associated with KDM4B variation, we first
compared the clinical features and MRIs of each of the in-
dividuals identified. All were diagnosed with GDD and/or
ID and language and gross motor skills were found to be
the most affected; language delay was present in eight
out of nine and gross motor delay was present in six out
of nine of the individuals. Three of the individuals (I:2,
I:4, and I:7) had a history of seizures, and four of themThe American Jour(I:1, I:2, I:5, and I:7) had structural anomalies appreciated
on their brain MRIs ranging from agenesis of the corpus
callosum with hydrocephalus to cystic formations, poly-
microgyria, and abnormal formation of the hippocampus
(Figure 2). Only one of the individuals (I:6) was microce-
phalic. Dysmorphic features were present in this cohort
as well, including abnormal palpebral fissures, short phil-
trum, sparse hair, and clinodactyly (Table S1).
Seven of the individuals (I:1–I:5, I:7, and I:8) harbored de
novo variants, while two (I:6 and I:9) inherited them from
affected parents. Four of the variants were missense, three
were frameshift, one was a single synonymous substitution
predicted to lead to a splicing defect, and one was a canon-
ical splicing variant leading to loss of function (Figures 1A
and S1). The combined annotation dependent depletion
(CADD) scores of the missense variants ranged from 25.4
to 32, and all identified variants were absent from gno-
mAD, including the inherited variants from I:6 and I:9,
which were identified through this study.19 According to
data from gnomAD, KDM4B has a significantly reduced
number of truncating and missense variants in controls,
indicating a constraint on both types of variants in a con-
trol population (probability of being loss-of-function intol-
erant [pLi] ¼ 1, Z score for missense variants ¼ 3.48).
Molecular modeling was computed to assess how vari-
ants in KDM4B would affect the protein’s structure and
function. None of the missense variants showed a pre-
dicted effect on splicing. KDM4B has five domains, which
include two jumonji catalytic demethylase domains, one is
the N-terminal portion (JmjN) and one is the C-terminal
portion (JmjC) domain; a double tudor domain; and two
plant homeodomains (PHDs). The JmjC domain is the cat-
alytic domain of the protein, while the JmjN domain helps
to provide essential structure. The tudor domain binds the
histones, H3K23me2/3, allowing for demethylation.20 The
PHDs contain zinc fingers, which are important for
KDM4B’s ability to interact with the chromatin as well.
The variant in I:1, p.Pro1095Leu, is located at the tail of
KDM4B, which is a flexible region (Figure 1A). This variant
may not impair the structure of KDM4B, but it may alter
KDM4B’s interactions with binding partners. The variant
in I:2, p.His768Arg, is predicted to destabilize the zinc
knuckle that connects the two zinc fingers within the
PHD. This prediction is based on the structural similarity
between the zinc fingers of KDM4B and the BRPF1.
His768 has a similar localization in KDM4B to His300 in
BRPF1. His300 forms a close contact with a zinc molecule
and is important for the zinc knuckle structure. Because
His768 plays a similar role in KDM4B, the introduction
of arginine will most likely break the contact formed
with zinc, destabilizing the zinc knuckle structure as well
(Figure 1B). The variants in I:3 and I:7, p.Leu220Pro and
p.Arg222Trp, respectively, are both located within the cat-
alytic, JmjC domain. In I:3, the substitution of leucine for
proline will destroy the local helical structure of the cata-
lytic domain, most likely impairing KDM4B catalytic func-
tion (Figure 1B[1a and 1b]). In I:7, arginine is substitutednal of Human Genetics 107, 1170–1177, December 3, 2020 1171
Table 1. Clinical and Genetic Findings of Individuals with KDM4B Variants
Affected Individual
(I)/ Country I:1 (Italy) I:2 (USA)
I:3


























gnomAD frequency 0 0 0 0 0 0 0 0 0
CADD score 25.4 25.6 32    32  
Inheritance de novo de novo de novo de novo de novo paternally inherited de novo de novo maternally
inherited
Sex male male female male male female female male male
Family history NC parents from
Middle East and
consanguineous
NC NC NC father with learning
disabilities






Gross motor delay þ þ þ þ þ  þ  
Fine motor delay þ þ     þ þ 
Language delay þ þ þ þ þ þ þ þ 
GDD or ID þ, GDD þ, GDD þ, GDD þ, GDD þ, GDD and
mild ID
þ, GDD and severe
ID, IQ ¼ 50
þ, GDD þ, GDD and mild
ID, IQ 60–72
þ, mild ID





Seizures  þ, neonatal
seizures, none
since then
 þ, seizures starting
at 2.5 years
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Figure 1. KDM4B Variant Localization and Molecular Modeling
(A) KDM4B with domains and patient individual variants noted.
(B) Molecular modeling of the missense variants in individuals (I) 2, 3, and 7. (1a) shows the helix formed by the catalytic domain of
KDM4B. Residue Leu220 is in red. (2b) shows the local destruction of the helical structure when Pro220 is substituted. Pro220 is shown
in red. (2a) shows the residue Arg222 within the catalytic domain of KDM4B; Arg222 is highlighted in red. (2b) shows the substitution of
Arg222 for Trp222 in I:7, which creates a bulky hydrophobic side chain most likely altering the folding and stability of the helix forma-
tion; Trp222 is shown in red. (3a) shows His768 and the zinc knuckle formation; His768 highlighted in red. (3b) shows the unraveling of
the zinc knuckle with the substitution of Arg768 in I:2; Arg768 is shown in red.for tryptophan on the outside of the protein, creating a
bulky hydrophobic side chain, which most likely alters
the folding and stability of the helix (Figure 1B). The mo-
lecular modeling overall suggests that missense variants
in KDM4B lead to loss or reduction of KDM4B function.
We then assessed how KDM4B disruption impacts brain
anatomy and behavior through a mouse model, with a
focus on the size and shape of the brain structures. Mouse
mutants were generated with the knockout-first allele
method.21 The strategy relies on the identification of an
exon common to all transcript variants (exon 5), upstream
of which a LacZ cassette was inserted. Exon 5 of the Kdm4b
allele was flanked by loxP sequences bilaterally (Figure 3A).
The resulting Kdm4btm1a(EUCOMM)Wtsi mice were then
phenotyped.
At weaning age, mouse survival was assessed from 142
successfully genotyped mice originating from severalThe American Jourdifferent litters and derived from a heterozygous-by-het-
erozygous breeding scheme. We obtained the expected
number of wild type (WT) and heterozygous Kdm4bþ/
mice, but only five (3%) were homozygous and all were fe-
male mice, suggesting that the tm1a allele of Kdm4b is not
compatible with life in males. To determine the window of
death, we carried out a recessive lethality screen at mouse
embryonic day 14.5 (E14.5). The rate of homozygosity
was, as expected, 22.2% (eight out of 36 embryos assessed).
The reason underlying embryonic lethality in the homo-
zygous knockout mice is unknown and will require further
studies; however, these preliminary data suggest death’s
occurring late during development between E14.5 and
weaning age. Male and female Kdm4bþ/ mice were then
studied independently. The weights of Kdm4bþ/ mice
did not significantly differ from their litter-matched con-
trols (Table S3). In line with this, there were no significantnal of Human Genetics 107, 1170–1177, December 3, 2020 1173
Figure 2. MRI Findings in Individuals 2, 5,
and 7
I:2 hadmany abnormalities, including agen-
esis of the corpus callosum with a right
bundle of Probst (2A, black arrow), white
matter cysts (2B, asterisk), interhemispheric
cysts (2B, two asterisks), polymicrogyria
(2A and 2B, white arrows), and incompletely
rotated dysmorphic hippocampi with the
left decreased in volume (2A, thin arrows).
The following are not shown: absent left
fornix with right fornix fused with the
bundle of Probst, subcortical gray matter
heterotopia, stenogyria of the right hemi-
sphere (probably due to prior hydrocepha-
lus), and decreased white matter volume.
I:5 had a small right middle cranial fossa
meningocele (5A, arrow) and mega cisterna
magna (5B, two asterisks). I:7 also had
many abnormalities, including partial agenesis of the corpus callosum (7C, black arrow), polymicrogyria (7B and 7D, arrows), dysmor-
phic hippocampi (7D, thin arrows), interdigitation of the frontal lobes (7A, arrow), fused caudate and lentiform nuclei with absent ante-
rior limb internal capsule (7B, arrows), mega cisterna magna (7C, two asterisks), prominent tectum (7C, arrow), incompletely rotated
small vermis (7C, arrowhead), and hypoplastic brainstem (7C, asterisk). The following are not shown: dysmorphic partially fused
fornices, azygous ACA, small optic nerves, and small cerebellar hemispheres.differences when comparing to a set of 771 baseline con-
trols accumulated over a 1 year period (Figure 3F; Table S4).
Using a recently developed robust approach for the
assessment of 63 brain parameters across 15 distinct brain
regions, we analyzed neuroanatomical defects in adult
Kdm4bþ/ mice.22 This consisted of a systematic quantifi-
cation of the same coronal brain regions at Bregma
þ0.98 mm and Bregma 1.34 mm, as well as an additional
coronal section at Bregma 2.06 mm, to further charac-
terize the hippocampus and the corpus callosum. To mini-
mize variation due to sex and age, we only used male mice
aged 16 weeks for analysis. In the het mice, a large number
of neuroanatomical parameters were reduced in size when
compared to WTs with the exception of the ventricles,
which were enlarged in size by 92% (p ¼ 0.009) (Figures
3B and 3C). The total brain area parameter was signifi-
cantly reduced by 13.8% (p ¼ 0.0005) concomitantly
with smaller size of the dentate gyrus of the hippocampus
(25.3%, p¼ 6.9E5) and decreased height of the soma of
the corpus callosum (24.7%, p ¼ 0.01). At Bregma
2.06 mm, the small size of the dentate gyrus was
confirmed and interestingly the corpus callosum was ab-
sent (Figures 3D and 3E, Table S5), indicating corpus cal-
losum agenesis. Taken together, these results suggest a
contribution of Kdm4b in the regulation of the size of the
brain, the hippocampus, and the corpus callosum while
contributing to ventriculomegaly.
We also assessed whether haploinsufficiency of Kdm4b
could lead to behavioral abnormalities in a similar way to
the neuronal conditional homozygous knockout of Jmjd2b
(Kdm4b).15 Although open-field findings showed an over-
all increase of 20% in traveled distance between 2 to
4 min in the het mice, this hyperactive behavior was not
statistically significant (Figures 3G–3K).
In this study, we have identified nine individuals with
extremely rare variants in KDM4B and syndromic GDD.1174 The American Journal of Human Genetics 107, 1170–1177, DecWe have shown an overlap in the neuroanatomical
features of the het mice in our murine model with our
clinical cohort. In at least two of the three individuals
in the study for whom we could obtain MRI images, the
MRIs closely mirrored the alterations seen in the het
mouse cortex with agenesis of the corpus callosum and
dysmorphic hippocampi present. The remaining MRIs
were reported as normal, although we were unable to
obtain the images for formal review. Molecular modeling
of the missense variants suggests that these variants lead
to altered KDM4B folding, stability, catalytic activity,
and ultimately, loss or reduction of function. Because
KDM4B is a histone modifier that acts through lysine
demethylation, we hypothesize that the transcription of
target genes regulating brain anatomy, in particular the
morphology of the hippocampus and the corpus cal-
losum, are suppressed in a dose-dependent manner. The
mouse model therefore consistently shows neuroanatom-
ical difference, whereas the human cohort shows a range
of severity most likely secondary to the degree of KDM4B
haploinsufficiency.
Emerging data suggest that variants in chromatin modi-
fiers are an important cause of neurodevelopmental
disability ranging from intellectual disability to autism
and schizophrenia.23–26 Variants in lysine demethylases
(KDMs) and lysine methyltransferases (KTMs), in partic-
ular, are predicted to cause 22 different developmental
delay syndromes.27 These epigenetic modifications can
affect the future plasticity of neuronal networks, altering
a person’s ability to learn and remember.28 Further under-
standing of these mechanisms provides important insights
into neurogenesis and the broad field of developmental
disorders. A previous report on neuron-specific Kdm4b
(Jmjd2b) knockout mice by Fukiwara et al. shows that
KDM4B (JMJD2B) depletion in mice leads to alteration in
dendritic spines within the hippocampi.15 Dendritic spineember 3, 2020
Figure 3. Mouse Studies Reveal a Role of KDM4B in the Anatomy of the Brain
(A) Construction of the Kdm4btm1a(EUCOMM)Wtsi allele.
(B) Histograms for three heterozygous Kdm4bmice showing percentage difference relative to 40 WTs. The overlapping dots show actual
data points. To present areas and lengths on the same scale, the square root of areas was used. Inserts are full dot and box plots of WT
(black) versus Kdm4bþ/ mice (red) for each of the four significant parameters (total brain area, lateral ventricle area, corpus callosum
height, dentate gyrus length).
(legend continued on next page)
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alteration has previously been reported in other genetic
causes of GDD as well, including X-linked ID, Down
syndrome, and Fragile X syndrome, highlighting that
appropriate synapse formation is critical for neurodevelop-
ment.29 We hypothesize that dendritic spines within the
hippocampi may be altered in our human cohort, leading
to the developmental delay.
To conclude, this study shows that variants in KDM4B
can lead to syndromic GDD in humans, most likely
through dysregulation of corticogenesis. These data
provide insight into a mechanism of GDD; future studies
evaluating the transcriptional targets and their signaling
pathways will help to further elucidate the role of
KDM4B in neurodevelopment.Data and Code Availability
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